Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centre for Substance Use Research is a private UK research and consultancy organization focused on behavioural science, substance use research, and tobacco harm reduction. The company provides research support to clients seeking regulatory authorization for tobacco and nicotine products, including work related to PMTA, MRTP, and TPD submissions. Its services center on behavioral studies, prevalence research, risk perception, use-intention assessment, and public-health impact evaluation for electronic nicotine delivery systems and related products. The organization originated in academia, was previously known as Centre for Drug Misuse Research, and now operates as an independent commercial research entity based in Glasgow, Scotland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centre for Substance Use Research.